openPR Logo
Press release

Tuberculosis (TB) Treatment Market Share to Expand Significantly Amid Rising Drug-Resistant Cases and Global Health Initiatives | Valuates Reports

04-15-2025 09:21 AM CET | Advertising, Media Consulting, Marketing Research

Press release from: Valuates Reports

Tuberculosis (TB) Treatment Market
The global Tuberculosis (TB) Treatment market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

View sample report
https://reports.valuates.com/request/sample/QYRE-Auto-9U6180/Global_Tuberculosis_TB_Treatment_Market_Insights_Forecast_to_2028

Market Trends for Tuberculosis (TB) Treatment Market:

The global Tuberculosis (TB) Treatment Market is experiencing steady growth, driven by the rising prevalence of tuberculosis, the emergence of drug-resistant strains, and concerted global health initiatives aimed at combating the disease. Advancements in diagnostic techniques and the development of novel therapeutics are further enhancing treatment efficacy and patient outcomes.

Market Size and Revenue

The market size for TB treatments has been steadily increasing, with an expanding patient base, especially in developing countries. Increasing healthcare access, government support, and global programs are leading to greater adoption of advanced treatments. Rising awareness and diagnostic capabilities are contributing significantly to revenue growth in the market.

Market Share

Asia-Pacific holds a dominant market share, driven by high TB prevalence in countries such as India and China. This region benefits from substantial government-led healthcare initiatives aimed at improving TB treatment access. North America and Europe also contribute to market growth, with ongoing research, development, and the implementation of advanced TB treatment protocols.

Market Growth

The market growth is being fueled by the increasing prevalence of multidrug-resistant (MDR) and extensively drug-resistant (XDR) TB, necessitating the development of more effective and tailored treatment regimens. The use of digital health solutions, mobile applications, and telemedicine is supporting improved patient compliance and treatment adherence, further boosting market growth.

Market Analysis

The market analysis reveals that ongoing research into shorter treatment durations and drugs with fewer side effects is shaping the future of the TB treatment market. Collaboration between public and private sectors, as well as international health organizations, continues to drive innovation. Funding and support for TB eradication programs remain crucial for expanding treatment access and improving outcomes globally.

Segment by Type

• Isoniazid
• Rifampin (Rifadin, Rimactane)
• Ethambutol (Myambutol)
• Pyrazinamide

Segment by Application

• Active TB
• Latent TB

By Company

Johnson & Johnson, Otsuka Pharmaceutical Co., Ltd, Macleods Pharmaceutical Ltd, Dong-A ST Co., Ltd, Lupin Ltd, Janssen Products, LP, Mylan, Sanofi

View full report
https://reports.valuates.com/market-reports/QYRE-Auto-9U6180/global-tuberculosis-tb-treatment

Valuates,
4th Floor,
Balaraj's Arcade,
Whitefield Main road,
Bangalore 560066,

Valuates offers an extensive collection of market research reports that helps companies to take intelligent strategical decisions based on current and forecasted Market trends.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Tuberculosis (TB) Treatment Market Share to Expand Significantly Amid Rising Drug-Resistant Cases and Global Health Initiatives | Valuates Reports here

News-ID: 3971132 • Views:

More Releases from Valuates Reports

Bipolar Plates for Fuel Cells Market Share Driven by Clean Energy Initiatives an …
Bipolar Plates for Fuel Cells - Market Size The global market for Bipolar Plates for Fuel Cells was estimated to be worth US$ 397 million in 2023 and is forecast to a readjusted size of US$ 480.3 million by 2030 with a CAGR of 2.8% during the forecast period 2024-2030 View sample report https://reports.valuates.com/request/sample/QYRE-Auto-9L8937/Global_Bipolar_Plates_for_Fuel_Cells_Market_Outlook_2022 Overall Market Overview: The Bipolar Plates for Fuel Cells market is experiencing significant growth, driven by the global shift towards clean
Magnetic Refrigeration Market Share Driven by Energy Efficiency and Environmenta …
Magnetic Refrigeration Market Size The global market for Magnetic Refrigeration was valued at US$ 18.2 million in the year 2024 and is projected to reach a revised size of US$ 51.8 million by 2031, growing at a CAGR of 16.4% during the forecast period. View sample report https://reports.valuates.com/request/sample/QYRE-Auto-2D7500/Global_Magnetic_Refrigeration_Market_Insights_and_Forecast_to_2028 Overall Market Overview: The magnetic refrigeration market is experiencing significant growth, driven by the increasing demand for energy-efficient and environmentally friendly cooling solutions. Traditional refrigeration systems often
Hematology Analyzers & Reagents Market Share Driven by Advancements in Diagnosti …
Hematology Analyzers & Reagents Market Size The global market for Hematology Analyzers & Reagents was valued at US$ 9208 million in the year 2024 and is projected to reach a revised size of US$ 13800 million by 2031, growing at a CAGR of 6.0% during the forecast period. View sample report https://reports.valuates.com/request/sample/QYRE-Auto-1X7612/Global_Hematology_Analyzers_Reagents_Market_Insights_and_Forecast_to_2028 Overall Market Overview: The Hematology Analyzers & Reagents market is experiencing robust growth, driven by advancements in diagnostic technologies and an increasing global
Benchtop Fluoride Ion Meters Market Share Driven by Water Quality Monitoring and …
Benchtop Fluoride Ion Meters Market The global market for Benchtop Fluoride Ion Meters was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period. View sample report https://reports.valuates.com/request/sample/QYRE-Auto-34G9428/Global_Benchtop_Fluoride_Ion_Meters_Market_Insights_Forecast_to_2028 Overall Market Overview: The Benchtop Fluoride Ion Meters market is experiencing significant growth, driven by increasing concerns over water quality and the need for precise measurement tools

All 5 Releases


More Releases for Tuberculosis

Revolutionizing the Fight Against Tuberculosis: Global Anti-Tuberculosis Therape …
The global Anti-Tuberculosis (TB) Therapeutics Market is on the cusp of a transformative era, driven by urgent medical need, groundbreaking scientific advances, and expanding public-private partnerships. With an estimated 10 million new TB cases reported worldwide in 2022 and 1.4 million deaths, tuberculosis remains a leading infectious disease killer, commanding critical attention from healthcare providers, governments, and pharmaceutical innovators alike. As the world rallies to eliminate this centuries-old scourge, the
Latent Tuberculosis Infection Detection Market
Latent Tuberculosis Infection Detection Market worth $2.37 Bn by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd. InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Latent Tuberculosis Infection Detection Market - (By Brand (QFT-Plus), By Test Type (Tuberculin Skin Test (TST), Interferon Gamma Release Assay (IGRA)), By Application, By End-use), Trends, Industry Competition Analysis, Revenue and Forecast To 2031." According to the latest research
Tuberculosis (TB) Diagnostics Market - Detect, Diagnose, Defeat: Innovating Solu …
Newark, New Castle, USA - new report, titled Tuberculosis (TB) Diagnostics Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Tuberculosis (TB) Diagnostics market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Tuberculosis (TB) Diagnostics market. The report offers an overview of
Conquering Tuberculosis: Exploring the Innovations in Mycobacterium Tuberculosis …
The global mycobacterium tuberculosis treatment market was valued at US$ 1.97 Bn in 2021 and is expected to increase at a CAGR of 1.2% over the forecast period 2022-2032. Mycobacterium tuberculosis is a bacteria that causes tuberculosis (TB), which mostly affects the lungs. Tuberculosis is a major public health crisis concern; however, it can be cured and prevented. Adults are most often affected by tuberculosis during their most productive years. Over
World Tuberculosis Day - Tuberculosis, the invisible pandemic
Tuberculosis is a disease that, every year, kills as many as COVID-19 does. March 24, World Tuberculosis Day, marks the anniversary of a momentous occasion - the discovery of the bacterium which causes tuberculosis in 1882. More than a hundred years after its discovery, tuberculosis is still a global health crisis. It is the leading cause of death from a single infectious disease agent, killing close to as many people per
Ocular Tuberculosis Therapeutics Market To Expand On Account Of Rising Tuberculo …
Research Nester released a report titled “Ocular Tuberculosis Therapeutics Market: Global Demand Analysis & Opportunity Outlook 2027” which delivers detailed overview of the global ocular tuberculosis therapeutics market in terms of market segmentation by treatment, by end user and by region. Further, for the in-depth analysis, the report encompasses the industry growth drivers, restraints, supply and demand risk, market attractiveness, BPS analysis and Porter’s five force model. Ocular tuberculosis is a type